The goal of this prospective observational study is to evaluate advanced practice physiotherapy and orthopedic surgeon care and clinical outcomes for new patients with a peripheral musculoskeletal disorders consulting at the orthopedic outpatient clinic of the Hôpital Jean-Talon. The main questions it aims to answer are: 1. To describe the models of care at the Hôpital Jean-Talon orthopedic outpatient clinic; 2. To assess change in pain, disability, quality of life and pain catastrophizing at 6, 12 and 26 weeks after the initial evaluation; 3. To assess interprofessional collaboration between the advanced practice physiotherapists and orthopedic surgeons; 4. To assess patient satisfaction with care; 5. To assess waiting time before an initial consultation. Researchers will compare patients cared in the advanced practice physiotherapy and orthopedic surgeon group and the orthopedic surgeon only group.
Study Type
OBSERVATIONAL
Enrollment
104
Management of their musculoskeletal condition by an advanced practice physiotherapist and an orthopedic surgeon.
Management of their musculoskeletal condition by an orthopedic surgeon.
Centre de recherche de l'Hôpital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Brief pain inventory severity
Pain questionnaire (0-10; higher score=worse)
Time frame: 6 weeks (change from baseline)
Brief pain inventory severity
Pain questionnaire (0-10; higher score=worse)
Time frame: 12 weeks (change from baseline)
Brief pain inventory severity
Pain questionnaire (0-10; higher score=worse)
Time frame: 26 weeks (change from baseline)
Brief pain inventory inventory
Pain interference (disability) questionnaire (0-10; higher score=worse)
Time frame: 6 weeks (change from baseline)
Brief pain inventory inventory
Pain interference (disability) questionnaire (0-10; higher score=worse)
Time frame: 12 weeks (change from baseline)
Brief pain inventory inventory
Pain interference (disability) questionnaire (0-10; higher score=worse)
Time frame: 26 weeks (change from baseline)
Shortened Disability of the Arm, Shoulder and Hand (QuickDASH)
Disability questionnaire for upper extremity disorders (0-100; higher=worse)
Time frame: 6 weeks (change from baseline)
Shortened Disability of the Arm, Shoulder and Hand (QuickDASH)
Disability questionnaire for upper extremity disorders (0-100; higher=worse)
Time frame: 12 weeks (change from baseline)
Shortened Disability of the Arm, Shoulder and Hand (QuickDASH)
Disability questionnaire for upper extremity disorders (0-100; higher=worse)
Time frame: 26 weeks (change from baseline)
Hip disability and Osteoarthritis Outcomes Score (HOOS)
Disability questionnaire for hip disorders (0-100; higher=better)
Time frame: 6 weeks (change from baseline)
Hip disability and Osteoarthritis Outcomes Score (HOOS)
Disability questionnaire for hip disorders (0-100; higher=better)
Time frame: 12 weeks (change from baseline)
Hip disability and Osteoarthritis Outcomes Score (HOOS)
Disability questionnaire for hip disorders (0-100; higher=better)
Time frame: 26 weeks (change from baseline)
Knee injury and Osteoarthritis Outcomes Score (KOOS)
Disability questionnaire for knee disorders (0-100; higher=better)
Time frame: 6 weeks (change from baseline)
Knee injury and Osteoarthritis Outcomes Score (KOOS)
Disability questionnaire for knee disorders (0-100; higher=better)
Time frame: 12 weeks (change from baseline)
Knee injury and Osteoarthritis Outcomes Score (KOOS)
Disability questionnaire for knee disorders (0-100; higher=better)
Time frame: 26 weeks (change from baseline)
Foot and Ankle Ability Measure (FAAM)
Disability questionnaire for ankle/foot disorders (0-100; higher=better)
Time frame: 6 weeks (change from baseline)
Foot and Ankle Ability Measure (FAAM)
Disability questionnaire for ankle/foot disorders (0-100; higher=better)
Time frame: 12 weeks (change from baseline)
Foot and Ankle Ability Measure (FAAM)
Disability questionnaire for ankle/foot disorders (0-100; higher=better)
Time frame: 26 weeks (change from baseline)
EQ-5D-5L
Health-related quality of life questionnaire (to be converted in QALYs 0-1; higher=better)
Time frame: 6 weeks (change from baseline)
EQ-5D-5L
Health-related quality of life questionnaire (to be converted in QALYs 0-1; higher=better)
Time frame: 12 weeks (change from baseline)
EQ-5D-5L
Health-related quality of life questionnaire (to be converted in QALYs 0-1; higher=better)
Time frame: 26 weeks (change from baseline)
EQ-5D-VAS
Health-related quality of life questionnaire (0-100; higher=better)
Time frame: 6 weeks (change from baseline)
EQ-5D-VAS
Health-related quality of life questionnaire (0-100; higher=better)
Time frame: 12 weeks (change from baseline)
EQ-5D-VAS
Health-related quality of life questionnaire (0-100; higher=better)
Time frame: 26 weeks (change from baseline)
Pain Catastrophizing Scale (PCS)
Health-related quality of life questionnaire (0-50; higher=worse)
Time frame: 6 weeks (change from baseline)
Pain Catastrophizing Scale (PCS)
Health-related quality of life questionnaire (0-50; higher=worse)
Time frame: 12 weeks (change from baseline)
Pain Catastrophizing Scale (PCS)
Health-related quality of life questionnaire (0-50; higher=worse)
Time frame: 26 weeks (change from baseline)
Patient perceptions of team effectiveness (Patient-PTE)
Perceptions of team effectiveness questionnaire (24-144; higher=better)
Time frame: 0 week (post initial consultation)
modified validated version of the 9-item visit-specific satisfaction questionnaire (VSQ-9)
Patient satisfaction questionnaire (0-100; higher=better)
Time frame: 0 week (post initial consultation)
Modified MedRisk
Patient satisfaction questionnaire (0-100; higher=better)
Time frame: 12 weeks
Modified MedRisk
Patient satisfaction questionnaire (0-100; higher=better)
Time frame: 26 weeks
Provider perceptions of team effectiveness (Prodiver-PTE)
Perceptions of team effectiveness questionnaire (26-156; higher=better)
Time frame: Through study completion (once)
Waiting time
Waiting time (time in days and minutes)
Time frame: Pre-intervention
Adverse events
Rate of adverse events
Time frame: 12 weeks
Adverse events
Rate of adverse events
Time frame: 26 weeks
Treatment and compliance
Treatment received and % of treatment compliance
Time frame: 6 weeks
Treatment and compliance
Treatment received and % of treatment compliance
Time frame: 12 weeks
Treatment and compliance
Treatment received and % of treatment compliance
Time frame: 26 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.